SCHEMBL845255

SCHEMBL845255

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)C3CCC3)cc2)cc1)[C@@H]1CCCN1C(=O)C1CCC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 2/20 0.47
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
PTPN1 P18031 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
RHOC P08134 1/20 0.44
RHOA P61586 1/20 0.44
PABPC1 P11940 1/20 0.43
TSHR P16473 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844884 0.96 HTT (0.48) CYP2C9CYP2C19HTTNPC1LMNA
SCHEMBL844963 0.86 DGAT1 (0.47) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL845340 0.86 ALDH1A1 (0.43) CYP2C9CYP2C19HTTNPC1LMNA
SCHEMBL845234 0.86 RHOC (0.43) CYP2C9CYP2C19NPC1LMNAALDH1A1
SCHEMBL845030 0.85 ALDH1A1 (0.49) CYP2C9CYP2C19HTTNPC1LMNA
SCHEMBL845476 0.85 HPGD (0.46) CYP2C9NPC1LMNAALDH1A1MEN1
SCHEMBL845251 0.84 PABPC1 (0.50) CYP2C9CYP2C19HTTNPC1LMNA
SCHEMBL845500 0.82 HPGD (0.51) CYP2C9NPC1LMNAALDH1A1MEN1
SCHEMBL845495 0.82 HPGD (0.51) CYP2C9NPC1LMNAALDH1A1MEN1
SCHEMBL845258 0.82 MAPK1 (0.60) CYP2C9CYP2C19HTTNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed